KI enters drug development partnership with Canada

Published 2012-09-18 00:00. Updated 2016-02-07 14:57Denna sida på svenska

Karolinska Institutet and The Centre for Drug Research and Development (CDRD) in Canada have signed a Memorandum of Understanding (MoU) to facilitate drug development research collaborations between Canadian and Swedish researchers from the two organizations.

This MoU represents the shared understanding between KI and CDRD that greater collaboration and innovation is required in order to develop new medical therapeutics that will benefit the global community. KI and CDRD will partner on research projects and workshops in a wide range of therapeutic areas, as well as exchange programs to augment specialized drug development training opportunities.

CDRD and KI have already begun to identify mutual areas of interest and explore specific opportunities under this agreement – sharing information and ideas on potential joint research projects directed towards the development of new medical therapeutics to benefit people across the world.

"CDRD continues to expand our network of world-leading affiliated institutions around the globe, and we are extremely pleased to be entering into this agreement with Karolinska Institutet, one of Europe's pre-eminent medical universities," said Karimah Es Sabar, President and CEO of CDRD.

"Both our organizations recognize the many shared benefits of international alliances - including the sharing of knowledge and accelerating the development of much-needed medical therapeutics."

"At Karolinska Institutet, we are very enthusiastic about this agreement with CDRD. It is important to us to build and leverage international networks in order to be on the frontier of research, education, and innovation - and our overall relationship with Canada has in recent years grown very strong," said Ola Hermanson, senior scientist and scientific coordinator for relations with Canada at Karolinska Institutet.

"Now building this subsequent relationship with CDRD is of particular value due to the Centre's unique structure and high profile. We are confident that this is the start of a strong and synergistic collaboration that will yield novel technologies and treatments for diseases with unmet medical needs."

About CDRD

The Centre for Drug Research and Development (CDRD) is a national not-for-profit drug development and commercialization centre headquartered in Vancouver, Canada that provides expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. In doing so, we de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector  successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canadas Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).